Sowa Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-374
Closed -$57K 133
2020
Q4
$57K Buy
374
+254
+212% +$36.3K 0.04% 124
2020
Q3
$16K Hold
120
0.01% 193
2020
Q2
$16K Hold
120
0.01% 190
2020
Q1
$13K Hold
120
0.01% 189
2019
Q4
$14K Buy
+120
New +$13.4K 0.01% 201

Other funds holding IBB

Sowa Financial Group's IBB Position: Q1 2021 in Review

Sowa Financial Group sold out of iShares Biotechnology ETF (IBB) in Q1 2021, closing a stake of 374 shares — an estimated $57K sold.

Sowa Financial Group first reported a position in IBB in Q4 2019 and held it in 5 quarters. The position peaked at $57K in Q4 2020. 845 funds tracked by Wall St. Rank hold IBB as of Q1 2021.

  • Sowa Financial Group reported no remaining iShares Biotechnology ETF position as of Q1 2021 after selling out during the quarter.
  • Sowa Financial Group sold 374 iShares Biotechnology ETF shares in Q1 2021, an estimated $57K.
  • Sowa Financial Group first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 5 quarters.
  • Sowa Financial Group's iShares Biotechnology ETF position peaked at $57K in Q4 2020.
  • 845 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2021.

Based on Sowa Financial Group's 13F filing for Q1 2021, filed 7 Apr 2021.